Medications for Soft Tissue Abscess
Incision and drainage is the primary treatment for soft tissue abscesses, and antibiotics are only indicated when specific complicating factors are present. 1, 2
When Antibiotics Are NOT Required
For simple, uncomplicated abscesses that can be completely drained, antibiotics are unnecessary if the patient meets ALL of the following criteria: 1, 3
- No fever, tachycardia, tachypnea, or leukocytosis 3
- No extensive cellulitis (less than 5 cm of surrounding erythema) 3
- Immunocompetent status 1, 3
- Abscess in an easily drainable location 1
- Good response to incision and drainage alone 1
When Antibiotics ARE Required
Antibiotic therapy is mandatory for abscesses with any of the following conditions: 1
- Severe or extensive disease involving multiple sites 1
- Rapid progression with associated cellulitis 1
- Signs of systemic illness (fever, tachycardia, SIRS criteria) 1, 3
- Immunosuppression or significant comorbidities 1
- Extremes of age 1
- Difficult-to-drain locations (face, hand, genitalia) 1
- Associated septic phlebitis 1
- Lack of response to incision and drainage alone 1
- Extensive purulent cellulitis (>5 cm of erythema) 3
Outpatient Oral Antibiotic Options
For empirical coverage of community-acquired MRSA (CA-MRSA), which is the most common pathogen, the following oral options are recommended: 1
First-Line Agents (MRSA Coverage):
- Clindamycin 300-450 mg orally three times daily - provides excellent coverage against both MRSA and β-hemolytic streptococci 1, 3, 4
- Trimethoprim-sulfamethoxazole (TMP-SMX) 1-2 double-strength tablets (160-800 mg) twice daily - excellent MRSA coverage but limited activity against streptococci 1, 3, 4
- Doxycycline or minocycline 100 mg twice daily - effective against MRSA but limited streptococcal coverage; avoid in children <8 years and pregnant women 1, 4
- Linezolid 600 mg twice daily - covers both MRSA and streptococci but significantly more expensive 1, 4
When Dual Coverage for Streptococci and MRSA is Needed:
- Clindamycin alone (covers both) 1
- TMP-SMX or tetracycline PLUS amoxicillin (to add streptococcal coverage) 1
- Linezolid alone (covers both) 1
For Methicillin-Susceptible S. aureus (MSSA) - If Known:
Inpatient Intravenous Antibiotic Options
For hospitalized patients with complicated abscesses (major abscesses, extensive cellulitis, systemic illness), empirical MRSA coverage is essential: 1
- Vancomycin 15 mg/kg IV every 12 hours (drug of choice for severe MRSA infections requiring IV therapy) 1, 4
- Linezolid 600 mg IV/PO twice daily 1
- Daptomycin 4 mg/kg IV once daily 1, 5
- Telavancin 10 mg/kg IV once daily 1
- Clindamycin 600 mg IV three times daily 1
For non-purulent cellulitis without confirmed MRSA, cefazolin may be considered with modification to MRSA-active therapy if no clinical response occurs 1
Duration of Therapy
The recommended duration is 5-10 days, individualized based on clinical response. 1, 3, 4 Treatment should be extended only if the infection has not improved within this timeframe 3, 4
Pediatric Considerations
- Mupirocin 2% topical ointment for minor skin infections 1
- Tetracyclines are contraindicated in children <8 years of age 1
- Vancomycin is the preferred agent for hospitalized children with complicated abscesses 1
- Clindamycin 10-13 mg/kg/dose IV every 6-8 hours (40 mg/kg/day) if clindamycin resistance is low (<10%) and patient is stable 1
- Linezolid: 600 mg twice daily for children >12 years; 10 mg/kg every 8 hours for children <12 years 1
Critical Management Points
Cultures should be obtained when: 1
- Antibiotics are prescribed 3
- Severe local infection or systemic illness is present 1
- Inadequate response to initial treatment 1
- Concern for outbreak or cluster 1
Common pitfall: Delaying or omitting incision and drainage will result in treatment failure regardless of antibiotic choice - drainage is the definitive treatment 4
Rifampin should NOT be used as single agent or adjunctive therapy for soft tissue abscesses 1